The Enterprise Value as of December 2025 (TTM) for Harbin Pharmaceutical Group Co., Ltd. (600664.SS) is 9.06B

According to Harbin Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 9.06B. This represents a change of 7.40% compared to the average of 8.44B of the last 4 quarters.

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) Historical Enterprise Value (quarterly & annually)

How has 600664.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Harbin Pharmaceutical Group Co., Ltd. over the last ten years is 10.89B. The current 9.06B Enterprise Value has changed 8.23% with respect to the historical average. Over the past ten years (40 quarters), 600664.SS's Enterprise Value was at its highest in in the December 2015 quarter at 21.32B. The Enterprise Value was at its lowest in in the March 2024 quarter at 6.73B.

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Harbin Pharmaceutical Group Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) Average Enterprise Value

How has 600664.SS Enterprise Value performed in the past?

The current Enterprise Value of Harbin Pharmaceutical Group Co., Ltd. (600664.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) Enterprise Value vs. Peers

How is 600664.SS’s Enterprise Value compared to its peers?

Harbin Pharmaceutical Group Co., Ltd.’s Enterprise Value is greater than Shandong Xinhua Pharmaceutical Company Limited (8.67B), less than Tianjin Ringpu Bio-Technology Co.,Ltd. (10.22B), greater than Cisen Pharmaceutical Co., Ltd. (7.79B), greater than Renhe Pharmacy Co., Ltd. (7.37B), greater than Zhejiang Xianju Pharmaceutical Co.,Ltd. (8.13B), less than KPC Pharmaceuticals, Inc. (10.45B), less than Shandong Lukang Pharmaceutical Co.,Ltd. (10.71B), greater than Sichuan Huiyu Pharmaceutical Co., Ltd. (6.19B), greater than Northeast Pharmaceutical Group Co., Ltd. (8.17B), greater than Jiangsu Kanion Pharmaceutical Co.,Ltd. (6.05B),

Build a custom stock screener for Harbin Pharmaceutical Group Co., Ltd. (600664.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harbin Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harbin Pharmaceutical Group Co., Ltd. (600664.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harbin Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.